These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12189644)

  • 41. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunophenotyping is an independent factor for risk stratification in AML.
    Repp R; Schaekel U; Helm G; Thiede C; Soucek S; Pascheberg U; Wandt H; Aulitzky W; Bodenstein H; Sonnen R; Link H; Ehninger G; Gramatzki M;
    Cytometry B Clin Cytom; 2003 May; 53(1):11-9. PubMed ID: 12717686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of CD56 in acute leukemia and its clinical significance].
    Zhang Y; Tang YM; Yang SL; Shen HQ; Qian BQ; Song H; Shi SW; Xu WQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):187-90. PubMed ID: 12513782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis.
    Xu S; Li X; Zhang J; Chen J
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1859-70. PubMed ID: 25924702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of immunoglobulin and T cell receptor gene rearrangements in patients with acute myeloid leukemia: Taiwan experience.
    Yen CC; Liu JH; Wang WS; Chiou TJ; Fan FS; Chen PM
    Leuk Lymphoma; 1999 Sep; 35(1-2):179-87. PubMed ID: 10512175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
    Thomas X; Vila L; Campos L; Sabido O; Archimbaud E
    Leuk Lymphoma; 1995 Oct; 19(3-4):295-300. PubMed ID: 8535222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia.
    Ogata K; Yokose N; Shioi Y; Ishida Y; Tomiyama J; Hamaguchi H; Yagasaki F; Bessyo M; Sakamaki H; Dan K; Kuriya S
    Br J Haematol; 2001 Dec; 115(3):612-5. PubMed ID: 11736944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical characteristics of CD56(+) patients with acute monocytic leukemia and their prognostic significance].
    Yang LL; Gan SL; Liu YF; Zhang QT; Li T; Ma J; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):596-600. PubMed ID: 23815905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
    Aref S; Abousamra N; El-Helaly E; Mabed M
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.
    Liang T; Peng Z; Li C; Huang J; Wang H; Bu C; Li J; Zheng Y; Feng X; Li H; Chen C
    BMC Cancer; 2022 Dec; 22(1):1339. PubMed ID: 36544113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The importance of CD7 and CD56 antigens in acute leukaemias.
    Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
    Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potential.
    Zaidi SZ; Motabi IH; Al-Shanqeeti A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):129-30. PubMed ID: 26706848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific skin manifestations in CD56 positive acute myeloid leukemia.
    Kuwabara H; Nagai M; Yamaoka G; Ohnishi H; Kawakami K
    J Cutan Pathol; 1999 Jan; 26(1):1-5. PubMed ID: 10189238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Intracranial Manifestation of CD7/CD56-Positive Acute Myelogenous Leukemia.
    Kahl C; Florschütz A; Jentsch-Ullrich K; Dietzmann K; Franke A
    Onkologie; 2000 Dec; 23(6):580-582. PubMed ID: 11441265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of CD56 and CD7 in acute myeloid leukaemia and their outcome.
    Rai S; Singh S; Gupta R
    Am J Blood Res; 2020; 10(4):109-117. PubMed ID: 32923090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.
    Alegretti AP; Bittar CM; Bittencourt R; Piccoli AK; Schneider L; Silla LM; Bó SD; Xavier RM
    Rev Bras Hematol Hemoter; 2011; 33(3):202-6. PubMed ID: 23049296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults.
    Hu W; Wang X; Yang R; Bi L; Xie Y; Zhang Z; Lu H; Wu L
    Hematology; 2017 Mar; 22(2):81-87. PubMed ID: 27734763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor.
    Macdonald D; Jiang YZ; Swirsky D; Vulliamy T; Morilla R; Bungey J; Barrett AJ
    Br J Haematol; 1991 Jan; 77(1):43-9. PubMed ID: 1998596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.